Cargando…

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extremely dense stroma, which has a fundamental role in tumor progression. Fibronectin (FN1) is the main constituent of the tumor stroma in pancreatic cancer. This study aimed to explore the association between FN1 and clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Dingyuan, Ansari, Daniel, Zhou, Qimin, Sasor, Agata, Said Hilmersson, Katarzyna, Andersson, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368702/ https://www.ncbi.nlm.nih.gov/pubmed/30736807 http://dx.doi.org/10.1186/s12957-019-1574-z

Ejemplares similares

Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
por: Zhou, Qimin, et al.
Publicado: (2020)

Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
por: Zhou, Qimin, et al.
Publicado: (2019)

Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
por: Byrling, J., et al.
Publicado: (2021)

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017)

Proteomic and genomic profiling of pancreatic cancer
por: Ansari, Daniel, et al.
Publicado: (2019)

SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer
por: Vaz, Juan, et al.
Publicado: (2015)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
por: Byrling, Johannes, et al.
Publicado: (2020)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
por: Bengtsson, Axel, et al.
Publicado: (2020)

Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
por: Kriz, D., et al.
Publicado: (2020)

Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma
por: Lintern, Nicole, et al.
Publicado: (2023)

Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
por: Sato, Daisuke, et al.
Publicado: (2016)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma
por: Wilson, Gregory C., et al.
Publicado: (2023)

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance
por: Vizio, Barbara, et al.
Publicado: (2018)

Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma
por: Suzuki, Yukie, et al.
Publicado: (2020)

Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection
por: Drifka, Cole R., et al.
Publicado: (2016)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma
por: Sperb, Nadine, et al.
Publicado: (2020)

B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
por: Minici, Claudia, et al.
Publicado: (2020)

Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma
por: Ray, Arja, et al.
Publicado: (2022)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma
por: Zhang, Jianli, et al.
Publicado: (2014)

Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma
por: Hartley, Christopher, et al.
Publicado: (2020)

Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
por: Vay, Christian, et al.
Publicado: (2022)

The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma
por: Kawahara, Kenji, et al.
Publicado: (2022)

Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma
por: Mascharak, Shamik, et al.
Publicado: (2023)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tb75au2r9d7aahhsefblgqs7ff